Mirum Pharmaceuticals, Inc. (MIRM) /
The debt of Mirum Pharmaceuticals, Inc. over the past 7 years
Chart Mirum Pharmaceuticals, Inc.: liquid cash, total debt, net cash, fiscal 2019–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Mirum Pharmaceuticals, Inc. had liquid cash of $383.33M and total debt of $309.8M: net cash of $73.53M. It had more liquid cash than debt at 4 of the 6 year-ends shown. Total debt was highest at the end of fiscal 2025 ($309.8M) and lowest at the end of fiscal 2019 ($0). No net cash figure is on file for fiscal 2022.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $383.33M* | $309.8M | $73.53M |
| 2024ended Dec 31, 2024 | $280.31M* | $308.08M | -$27.77M |
| 2023ended Dec 31, 2023 | $286.33M* | $306.42M | -$20.09M |
| 2022ended Dec 31, 2022 | $151.72M* | — | — |
| 2021ended Dec 31, 2021 | $156.54M* | $0 | $156.54M |
| 2020ended Dec 31, 2020 | $231.82M* | $0 | $231.82M |
| 2019ended Dec 31, 2019 | $116.66M* | $0 | $116.66M |
Fiscal years as Mirum Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Mirum Pharmaceuticals, Inc.
- The revenue of Mirum Pharmaceuticals, Inc.
- The profitability of Mirum Pharmaceuticals, Inc.
- The cash flow of Mirum Pharmaceuticals, Inc.
- All of Mirum Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- CNOCNO Financial Group, Inc.
- AROCArchrock, Inc.
- BRZEBraze, Inc.
- TENBTENABLE HOLDINGS, INC.
- UNFUNIFIRST CORPORATION
Not investment advice. This page shows what Mirum Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.